National Taiwan University Hospital
Taipei, Taiwan
Location status: Recruiting
Location contact
Kuang-Cheng Chan
CONTACT
NCT Number: NCT06215404
During liver transplantation, due to the complexity of the operation and abnormal coagulation function, there may be a large amount of bleeding and corresponding blood transfusion. Excessive blood transfusion will increase pulmonary complications and affect the prognosis. Infusion management to reduce bleeding is a very important issue in liver transplant surgery. Restrictive infusion management can effectively reduce the amount of bleeding in liver transplantation, but it remains unclear whether it will cause sequelae in other major organs.
The investigators plan to study different infusion goals and strategies in liver transplant surgery using a randomized group model, using the PiCCO (Pulse Contour Cardiac Output) cardiopulmonary volume monitor, and setting the stroke volume variation (SVV) as the macroscopic circulation.The purpose of this study was to divide it into restrictive and liberal groups to explore the impact on liver transplantation bleeding volume and inflammatory response as well as postoperative lung and renal function, and to collect statistics on clinical care and postoperative sequelae (pulmonary liver, renal function impairment, etc.) in order to develop the most appropriate infusion management strategy in liver transplantation.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Not applicable
Taipei, Taiwan
Location status: Recruiting
Kuang-Cheng Chan
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fluid challage to keep stroke volume variation < 10%
Fluid challage to keep stroke volume variation < 18%
Time frame: during the operation
blood loss intraoperatively in liver transplant
Time frame: from biginning of the operation to postoprative day 1
serum Clara Cell Protein (CC16)
Time frame: from biginning of the operation to postoprative day 1
serum Neutrophil Gelatinase Associated Lipocalins (NGALs)
Time frame: from biginning of the operation to postoprative day 1
IL-6
Contact information is provided by the study sponsor or research team.
National Taiwan University Hospital
Other
Effects of Different Fluid Management Strategies on Blood Loss, Inflammatory Response, and Major Organ Sequelae in Liver Transplantation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04312958
Cardiovascular Diseases, Embolism and Thrombosis
San Francisco, California, United States
View Trial DetailsNCT06280950
Liver Transplant
Phoenix, Arizona, United States
View Trial DetailsNCT06075745
Liver Transplant
Birmingham, Alabama, United States
View Trial DetailsNCT07549503
Liver Transplant
San Francisco, California, United States
View Trial Details